Literature DB >> 24290838

Higher insulin and glucagon-like peptide-1 (GLP-1) levels in healthy, young South Asians as compared to Caucasians during an oral glucose tolerance test.

Maria A Sleddering1, Leontine E H Bakker2, Laura G M Janssen2, A Edo Meinders2, Ingrid M Jazet2.   

Abstract

OBJECTIVE: Higher insulin levels during an oral glucose test (OGTT) have been shown in South Asians. We aimed to investigate if this increased insulin response causes reactive hypoglycemia later on, and if an increased glucagon-like-peptide-1 (GLP-1) response, which could contribute to the hyperinsulinemia, is present in this ethnic group.
METHODS: A prolonged, 6-h, 75-g OGTT was performed in healthy, young Caucasian (n=10) and South Asian (n=8) men. The glucose, insulin and GLP-1 response was measured and indices of insulin sensitivity and beta-cell activity were calculated.
RESULTS: Age (Caucasians (CAU) 21.5±0.7 years vs South Asians (SA) 21.4±0.7 years (mean±SEM)) and body mass index (CAU 22.7±0.7 kg/m(2) vs SA 22.1±0.8 kg/m(2)) were comparable between the two groups. South Asian men were more insulin resistant, as indicated by a comparable glucose but significantly higher insulin response, and a significantly lower Matsuda index (CAU 8.7(8.6) vs SA 3.2(19.2), median(IQR)). South Asians showed a higher GLP-1 response, as reflected by a higher area under the curve for GLP-1 (CAU 851±99.8 mmol/l vs SA 1235±155.0 mmol/L). During the whole 6-h period, no reactive hypoglycemia was observed.
CONCLUSION: Healthy, young South Asian men have higher insulin levels during an OGTT as compared to Caucasians. This does not, however, lead to reactive hypoglycemia. The hyperinsulinemia is accompanied by increased levels of GLP-1. Whether this is an adaptive response to facilitate hyperinsulinemia to overcome insulin resistance or reflects a GLP-1 resistant state has yet to be elucidated.
© 2013.

Entities:  

Keywords:  AUC; BMI; CAU; Caucasian; DI(o); DPP-IV; Dipeptidyl peptidase IV; GLP-1; IGI; IQR; Insulin resistance; Insulin sensitivity; OGTT; SA; SEM; South Asian; T2DM; area under the curve; body mass index; glucagon-like-peptide-1; insulinogenic index; interquartile range; oral disposition index; oral glucose tolerance test; standard error of the mean; type 2 diabetes mellitus.

Mesh:

Substances:

Year:  2013        PMID: 24290838     DOI: 10.1016/j.metabol.2013.10.008

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

1.  Dietary patterns are associated with metabolic risk factors in South Asians living in the United States.

Authors:  Meghana D Gadgil; Cheryl A M Anderson; Namratha R Kandula; Alka M Kanaya
Journal:  J Nutr       Date:  2015-04-22       Impact factor: 4.798

2.  Fasting glucagon-like peptide 1 concentration is associated with lower carbohydrate intake and increases with overeating.

Authors:  A Basolo; S Heinitz; E J Stinson; B Begaye; M Hohenadel; P Piaggi; J Krakoff; S B Votruba
Journal:  J Endocrinol Invest       Date:  2018-10-03       Impact factor: 4.256

3.  Glucagon-like peptide-1 as predictor of body mass index and dentate gyrus neurogenesis: neuroplasticity and the metabolic milieu.

Authors:  Jeremy D Coplan; Shariful Syed; Tarique D Perera; Sasha L Fulton; Mary Ann Banerji; Andrew J Dwork; John G Kral
Journal:  Neural Plast       Date:  2014-11-23       Impact factor: 3.599

Review 4.  Incretin response in Asian type 2 diabetes: Are Indians different?

Authors:  Awadhesh Kumar Singh
Journal:  Indian J Endocrinol Metab       Date:  2015 Jan-Feb

5.  Glucagon-like peptide 1 and dysglycemia: Conflict in incretin science.

Authors:  Awadhesh Kumar Singh
Journal:  Indian J Endocrinol Metab       Date:  2015 Jan-Feb

6.  Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus.

Authors:  Xiao-Li Wang; Fang Ye; Jun Li; Ling-Yun Zhu; Gang Feng; Xiang-Yun Chang; Kan Sun
Journal:  Saudi Med J       Date:  2016-01       Impact factor: 1.484

7.  Substantial Inter-Subject Variability in Blood Pressure Responses to Glucose in a Healthy, Non-obese Population.

Authors:  Cathriona R Monnard; Benoît Fellay; Isabelle Scerri; Erik K Grasser
Journal:  Front Physiol       Date:  2017-07-18       Impact factor: 4.566

8.  Contribution of insulin resistance to decreased baroreceptor sensitivity & cardiometabolic risks in pre-obesity & obesity.

Authors:  Jagadeeswaran Indumathy; Gopal Krushna Pal; Pravati Pal; Palakkad Hariharan Ananthanarayanan; Subash Chandra Parija; Jayaraman Balachander; Tarun Kumar Dutta
Journal:  Indian J Med Res       Date:  2018-08       Impact factor: 2.375

9.  Effect of sitagliptin on energy metabolism and brown adipose tissue in overweight individuals with prediabetes: a randomised placebo-controlled trial.

Authors:  Kimberly J Nahon; Fleur Doornink; Maaike E Straat; Kani Botani; Borja Martinez-Tellez; Gustavo Abreu-Vieira; Jan B van Klinken; Gardi J Voortman; Edith C H Friesema; Jonatan R Ruiz; Floris H P van Velden; Lioe-Fee de Geus-Oei; Frits Smit; Lenka M Pereira Arias-Bouda; Jimmy F P Berbée; Ingrid M Jazet; Mariëtte R Boon; Patrick C N Rensen
Journal:  Diabetologia       Date:  2018-08-25       Impact factor: 10.122

10.  Expected values for gastrointestinal and pancreatic hormone concentrations in healthy volunteers in the fasting and postprandial state.

Authors:  Claire L Meek; Hannah B Lewis; Keith Burling; Frank Reimann; Fiona Gribble
Journal:  Ann Clin Biochem       Date:  2020-12-07       Impact factor: 2.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.